Arcturus Therapeutics Holdings Inc: BTIG cuts target price to $20 from $23
ARCT•BTIG cut its target price for Arcturus Therapeutics Holdings to $20 from $23.
Related News
Biodesix advances two complementary approaches to molecular residual disease (MRD) monitoring
BDSX•
Quanta Services upgraded to outperform; price target raised to $775 from $748
PWR•
Artificial Intelligence Technology Solutions and subsidiary announce hardware price increase
AITX•
Kyverna reports positive 1-year KYSA-8 trial data for miv-cel in stiff person syndrome
KYTX•
Perfect says 1H 2026 revenue rises 5.9% on YouCam subscription growth
PERF•